Tag: muscle wasting disorders market share

  • 2024-2033 Global Muscle Wasting Disorders Market Outlook: Projected Size and Growth Rate

    2024-2033 Global Muscle Wasting Disorders Market Outlook: Projected Size and Growth Rate

    Save up to 30% on The Business Research Company’s comprehensive market research reports for a limited time only!

    What is the Expected Growth Rate of the Muscle Wasting Disorders Market from 2024 to 2033?

    The muscle wasting disorders market has grown rapidly in recent years. It is anticipated to rise from $12.91 billion in 2023 to $15.06 billion in 2024, reflecting a CAGR of 16.6%. This growth is driven by an aging population, the rising incidence of chronic diseases, advancements in research and development, increased awareness of early diagnosis, and emerging therapeutic approaches.

    The muscle wasting disorders market is expected to see rapid growth, reaching $26.11 billion by 2028 at a CAGR of 14.8%. The growth is driven by regulatory support, patient advocacy initiatives, development of healthcare infrastructure, globalization of clinical trials, and personalized medicine approaches. Key trends include the adoption of telemedicine, technological advancements in diagnostics, product innovation, collaborations and partnerships, advancements in therapeutics, research on molecular mechanisms, and biopharmaceutical innovation.

    Claim Your Free Sample of the Global Muscle Wasting Disorders Market Report Today!

    https://www.thebusinessresearchcompany.com/sample.aspx?id=13706&type=smp

    What Key Factors Are Fueling the Growth of the Muscle Wasting Disorders Market?

    A sedentary lifestyle is anticipated to propel the muscle wasting disorders market’s growth. A sedentary lifestyle, marked by physical inactivity, negatively impacts muscle function, reducing muscle strength and endurance and contributing to muscle wasting. According to the World Health Organization, a Switzerland-based intergovernmental organization, over 80% of adolescents and 27% of adults did not meet the recommended physical activity levels in 2022, which consequently contributes to muscle wasting disorder growth.

    What Are the Major Segments of the Muscle Wasting Disorders Market?

    1) By Treatment Type: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, Other Treatment Types

    2) By Disorder Type: Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), Other Disorder Types

    3) By End-User: Hospitals, Rehab Centers, Specialty Clinics, Other End-Users

    What New Trends Are Transforming the Muscle Wasting Disorders Market?

    Companies in the muscle wasting disorders market are focusing on developing innovative products like novel gene therapies. Gene therapy aims to treat conditions by altering gene expression or the biological properties of cells. For example, in June 2023, Sarepta Therapeutics introduced Elevidys, the first FDA-approved gene therapy for treating Duchenne muscular dystrophy (DMD) in young children. Elevidys is a recombinant gene therapy designed to introduce a shortened protein for muscle cell function, delivered through a single intravenous infusion.

    Order Now for Fast Delivery of Your Muscle Wasting Disorders Market Report!

    https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

    Which Regions Are Driving Growth in the Muscle Wasting Disorders Market?

    North America was the largest region in the muscle wasting disorder market in 2023. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in the muscle wasting disorders market report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East, Africa.

    The Muscle Wasting Disorders Global Market Report 2024 offers a comprehensive overview of the audio equipment market, covering historical data from 2010 to 2021 and providing a ten-year forecast from 2023 to 2032. This report examines the size of the muscle wasting disorders market, its market share, and analyzes key competitors along with their market positions.

    The Table Of Content For The Muscle Wasting Disorders Market Include

    1. Muscle Wasting Disorders Market Executive Summary

    2. Muscle Wasting Disorders Market Segments

    3. Muscle Wasting Disorders Market Size And Template Market Growth Rate

    4. Key Muscle Wasting Disorders Market Trends

    5. Major Muscle Wasting Disorders Market Drivers

    ……

    25. Key Mergers And Acquisitions In The Muscle Wasting Disorders Market

    26. Top Muscle Wasting Disorders Companies

    27. Muscle Wasting Disorders Market Opportunities And Strategies

    28. Muscle Wasting Disorders Market, Conclusions And Recommendations

    29. Appendix

    Discover Related Reports by The Business Research Company:

    Anorectal Disorders Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/anorectal-disorders-treatment-global-market-report

    Optic Nerve Disorders Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/optic-nerve-disorders-treatment-global-market-report

    Bleeding Disorders Treatment Global Market Report 2024

    https://www.thebusinessresearchcompany.com/report/bleeding-disorders-treatment-global-market-report

    Learn More About The Business Research Company

    The Business Research Company has published over 15000+ reports in 27 industries, spanning 60+ geographies. The reports draw on 1,500,000 datasets, extensive secondary research, and exclusive insights from interviews with industry leaders.

    Contact us at:

    The Business Research Company: https://www.thebusinessresearchcompany.com/

    Americas +1 3156230293

    Asia +44 2071930708

    Europe +44 2071930708

    Email us at info@tbrc.info

    Follow us on:

    LinkedIn: https://in.linkedin.com/company/the-business-research-company

    YouTube: https://www.youtube.com/channel/UC24_fI0rV8cR5DxlCpgmyFQ

    Global Market Model: https://www.thebusinessresearchcompany.com/global-market-model

    Found this article helpful? Share it on:

  • Key Trends And Drivers In The Muscle Wasting Disorders Market 2024

    Key Trends And Drivers In The Muscle Wasting Disorders Market 2024

    The Business Research Company’s market reports offer an in-depth analysis on the market’s growth potential, major drivers, key trends and more.

    Market Growth Dynamics

    Recent Market Growth

    • Significant Expansion: The muscle wasting disorders market has grown from $12.91 billion in 2023 to $15.06 billion in 2024.
    • CAGR: Achieved a compound annual growth rate (CAGR) of 16.6% in recent years.
    • Drivers: Growth attributed to aging population, rising chronic diseases, R&D advancements, early diagnosis awareness, and emerging therapies.

    Future Market Projections

    • Projected Growth: Expected to reach $26.11 billion by 2028.
    • Forecast CAGR: Anticipated CAGR of 14.8%.
    • Factors: Driven by regulatory support, patient advocacy, healthcare infrastructure development, globalization of clinical trials, and personalized medicine approaches.

    Read More On The Muscle Wasting Disorders Market Report 2024 – https://www.thebusinessresearchcompany.com/report/muscle-wasting-disorders-global-market-report

    Sedentary Lifestyle and Market Growth

    Impact of Sedentary Lifestyle

    • Growing Concern: Rising adherence to sedentary lifestyles is a significant factor fueling market growth.
    • Consequences: Sedentary behavior contributes to muscle weakening and increased susceptibility to muscle wasting disorders.
    • Statistics: Over 80% of adolescents and 27% of adults did not meet WHO physical activity recommendations in 2022.

    Key Players in the Market

    Major Companies

    • Industry Leaders: Pfizer Inc., Roche Holding AG, Novartis AG, Sanofi, GSK, among others.
    • Diverse Offerings: These companies provide a range of treatments and therapies for muscle wasting disorders.

    Innovations in Therapeutics

    Advancements in Gene Therapy

    • Technological Breakthrough: Companies are focusing on gene therapy to address muscle wasting disorders.
    • Example: Sarepta Therapeutics’ Elevidys, FDA-approved gene therapy for Duchenne muscular dystrophy, represents a significant innovation.
    • Mechanism: Administered via single intravenous infusion to deliver targeted gene sequences.

    Strategic Acquisitions

    • Biogen’s Expansion: Biogen Inc.’s acquisition of Reata Pharmaceuticals enhances its rare disease portfolio with a focus on neuromuscular disorders like Friedreich’s ataxia.
    • Strategic Benefits: Strengthens Biogen’s position in treating muscle wasting disorders.

    Market Segmentation

    Treatment Types

    • Varied Approaches: Medications, Physical Therapy, Nutritional Therapy, Surgery, Gene Therapy, and Other Treatment Types.

    Disorder Types

    • Wide Spectrum: Includes Muscular Dystrophy, Amyotrophic Lateral Sclerosis (ALS), and Other Disorder Types.

    End Users

    • Diverse Applications: Hospitals, Rehab Centers, Specialty Clinics, and Other End Users.

    Regional Insights

    Geographic Influence

    • Current Leader: North America led the muscle wasting disorders market in 2023.
    • Growth Potential: Asia-Pacific expected to show the fastest growth in the forecast period.

    Conclusion

    The muscle wasting disorders market is experiencing rapid growth driven by factors such as increasing chronic diseases, technological advancements in gene therapy, and rising awareness of sedentary lifestyles’ impact. Innovations in therapeutic approaches, strategic acquisitions, and regional expansions underscore a dynamic market landscape poised for substantial growth and development in the coming years. As the market expands, collaborations and advancements in diagnostics and therapeutics will play pivotal roles in shaping future treatment paradigms for muscle wasting disorders globally.

    Request for A Sample Of The Global Muscle Wasting Disorders Market Report:
    https://www.thebusinessresearchcompany.com/sample_request?id=13706&type=smp